|
NAE1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.93850999999912E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.50364000000014E-05 |
| Normal-vs-Stage2 |
1.782150E-01 |
| Normal-vs-Stage3 |
4.675800E-03 |
| Normal-vs-Stage4 |
1.857270E-03 |
| Stage1-vs-Stage2 |
1.227610E-01 |
| Stage1-vs-Stage3 |
3.494000E-01 |
| Stage1-vs-Stage4 |
6.183000E-01 |
| Stage2-vs-Stage3 |
4.373400E-01 |
| Stage2-vs-Stage4 |
3.040000E-01 |
| Stage3-vs-Stage4 |
7.258200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.385100E-04 |
| Normal-vs-AfricanAmerican |
2.401000E-03 |
| Normal-vs-Asian |
3.60850000000745E-05 |
| Caucasian-vs-AfricanAmerican |
1.568750E-01 |
| Caucasian-vs-Asian |
5.544000E-02 |
| AfricanAmerican-vs-Asian |
9.901200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.168800E-04 |
| Normal-vs-Female |
4.44419999999779E-05 |
| Male-vs-Female |
7.663600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.86285000000064E-05 |
| Normal-vs-Age(41-60Yrs) |
2.379500E-04 |
| Normal-vs-Age(61-80Yrs) |
1.995740E-02 |
| Normal-vs-Age(81-100Yrs) |
2.361000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.484000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.377770E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.757950E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.956200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.497600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.541400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.690100E-02 |
| Classical-VS-Follicular |
3.418600E-04 |
| Classical-VS-Other |
3.181800E-01 |
| Classical-VS-Normal |
5.53600000285925E-08 |
| Tall-VS-Follicular |
3.766600E-01 |
| Tall-VS-Other |
9.844400E-01 |
| Tall-VS-Normal |
8.754300E-02 |
| Follicular-VS-Other |
7.058800E-01 |
| Follicular-VS-Normal |
4.696600E-01 |
| Other-VS-Normal |
2.973800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.741000E-03 |
| Normal-vs-N1 |
2.706300E-02 |
| N0-vs-N1 |
8.569400E-01 |
|
|
